Global Transcatheter Heart Valve Market Size To Worth USD 20.03 Billion By 2033 | CAGR of 15.67%

Category: Healthcare

RELEASE DATE Dec 2024
REPORT ID SI7772

Global Transcatheter Heart Valve Market Size To Worth USD 20.03 Billion By 2033

According to a research report published by Spherical Insights & Consulting, the Global Transcatheter Heart Valve Market Size is Expected to Grow from USD 4.67 Billion in 2023 to USD 20.03 Billion by 2033, at a CAGR of 15.67% during the forecast period 2023-2033.  

 Transcatheter Heart Valve Market

Get more details on this report -

Request Free Sample PDF

Browse key industry insights spread across 220 pages with 105 Market data tables and figures & charts from the report on the " Global Transcatheter Heart Valve Market Size, Share, and COVID-19 Impact Analysis, By Technology (Balloon Expanded Transcatheter Valve and Self-Expanded Transcatheter Valve), By Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, and Transcatheter Mitral Valve), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033. " Get Detailed Report Description Here:  https://www.sphericalinsights.com/reports/transcatheter-heart-valve-market      

 

Patients with valvular heart disease (VHD) who are not suitable candidates for surgery now have better results due to transcatheter heart valve treatments. These procedures have been extended to younger or lower-risk patients as well as those with different types of VHD due to technological advancements, and they can eventually allow for the early treatment of VHD in people with moderate illness or fewer symptoms. The transcatheter heart valve market is anticipated to be driven by the rising incidence of aortic stenosis. The launch of third-generation transcatheter heart valves, the rising incidence of valvular heart disorders, and advantageous reimbursement policies are the main factors driving the growth of the transcatheter heart valve market. The treatment of aortic stenosis, which primarily affects the elderly using transcatheter heart valves is anticipated to drive the market due to the key player's increased awareness campaigns. However, the transcatheter heart valve market is restricted by factors such as high prices, little awareness, difficulties with regulations, restrictions on the devices, and patient selection standards.   

 

The self-expanded transcatheter valve segment is predicted to hold the highest market share through the forecast period.

Based on the technology, the transcatheter heart valve market is classified into balloon expanded transcatheter valve, and self-expanded transcatheter valve. Among these, the self-expanded transcatheter valve segment is predicted to hold the highest market share through the forecast period. This is due to its substantial market presence, the self-expanded transcatheter valve category is mostly composed of first- and second-generation transcatheter heart valves.    

 

The transcatheter aortic valve segment is anticipated to hold the highest market share during the projected timeframe.    

Based on the application, the transcatheter heart valve market is divided into transcatheter aortic valve, transcatheter pulmonary valve, and transcatheter mitral valve. Among these, the transcatheter aortic valve segment is anticipated to hold the highest market share during the projected timeframe. Increases in severe aortic stenosis, chronic heart disease, and healthcare costs are the main factors driving the market in the transcatheter aortic valve segment.     

 

North America is estimated to hold the largest share of the transcatheter heart valve market over the forecast period.

 Transcatheter Heart Valve Market

Get more details on this report -

Request Free Sample PDF

North America is estimated to hold the largest share of the transcatheter heart valve market over the forecast period. Strong healthcare systems, a high prevalence of heart valve illnesses, and substantial research and development in the medical device market are the factors that define the U.S. transcatheter heart valve market. Transcatheter valve technology has been proactively approved by regulatory agencies including the FDA, which has driven commercial expansion.   

Asia Pacific is predicted to grow at the highest CAGR growth in the transcatheter heart valve market over the forecast period. The high prevalence of heart valve problems in Japan, especially among its senior population, is driving the transcatheter heart valve market. The adoption of THV procedures has been facilitated by Japan's robust regulatory framework and sophisticated healthcare infrastructure.  

Major key players in the transcatheter heart valve market include Medtronic, Abbott, Edwards Lifesciences, Meril Life Sciences, Symetis, Bracco Group, Direct Flow Medical, Braile Biomedica, ValveXchange, Inc., JenaValve, Boston Scientific Corporation, and Others.   

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Recent Development

  • In March 2024, for patients with symptomatic severe aortic stenosis, Medtronic announced that the FDA has authorized its Evolut FX+ transcatheter aortic valve replacement (TAVR) system. The diamond-shaped frame of this upgraded system provides improved coronary access while preserving the excellent valve performance for which the Evolut platform is renowned.  

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the transcatheter heart valve market based on the below-mentioned segments:

 

Global Transcatheter Heart Valve Market, By Technology  

  • Balloon Expanded Transcatheter Valve
  • Self-Expanded Transcatheter Valve

 

Global Transcatheter Heart Valve Market, By Application

  • Transcatheter Aortic Valve
  • Transcatheter Pulmonary Valve
  • Transcatheter Mitral Valve

 

Global Transcatheter Heart Valve Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies